SCHEMBL6521071

SCHEMBL6521071

O=c1[nH]c2nccc(Cl)c2c2ccc(OCCCN3CCOCC3)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.54
ACHE P22303 1/20 0.50
MAOA P21397 1/20 0.48
PARP1 P09874 1/20 0.47
EPHX2 P34913 4/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46
PRKAB2 O43741 1/20 0.45
PRKAG1 P54619 1/20 0.45
PRKAA2 P54646 1/20 0.45
PRKAA1 Q13131 1/20 0.45
PRKAG3 Q9UGI9 1/20 0.45
PRKAG2 Q9UGJ0 1/20 0.45
PRKAB1 Q9Y478 1/20 0.45
HRH3 Q9Y5N1 3/20 0.44
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523005 0.95 MAOA (0.53) SIGMAR1ACHEMAOAPARP1EPHX2
SCHEMBL6519482 0.78 SRC (0.57) MAOAPARP1ALDH1A1KDM4EAURKB
SCHEMBL6463317 0.77 GRM4 (0.58) SIGMAR1ACHEALDH1A1KDM4EHRH3
SCHEMBL15260249 0.74 ALDH1A1 (0.57) SIGMAR1ACHEEPHX2ALDH1A1KDM4E
SCHEMBL14495853 0.71 KDM4E (0.64) SIGMAR1ACHEMAOAALDH1A1KDM4E
SCHEMBL30499279 0.71 KDM4E (0.64) SIGMAR1ACHEMAOAALDH1A1KDM4E
SCHEMBL5493936 0.71 PIK3CD (0.57) SIGMAR1ACHEALDH1A1HRH3CYP1A2
SCHEMBL1797653 0.70 PARP1 (0.54) SIGMAR1ACHEMAOAPARP1HRH3
SCHEMBL1797758 0.70 PARP1 (0.57) SIGMAR1ACHEMAOAPARP1HRH3
SCHEMBL6519310 0.70 AURKA (0.70) PARP1ALDH1A1AURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
US-8735584-B2 Protein kinase inhibitors and use thereof MERCK PATENT GMBH (DE) 2014-05-27 US disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
EP-2254889-B1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2012-12-19 EP disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK PATENT GMBH (DE) 2011-03-03 US disclosed
WO-2009108670-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MERCK SERONO S.A. (CH) 2009-09-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053906-A1 PROTEIN KINASE INHIBITORS AND USE THEREOF MAP4K2, MAP3K20, MAP4K1 SIGMAR1 3268/4885ACHE 3695/4885MAOA 2577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.